As we approach the holiday season, it’s hard not to complain about the box office’s intent to release some high-profile films (until Red One on November 15th). Domestically, the box office is 20% higher than last year when The Marvels collapsed, but down 33% from 2019 levels when Terminator: Dark Fate bombed with a $29 million debut. Venom: The Last Dance, which yours indeed apologizes for not getting to cover last weekend, has the value only pertaining to it with the actor having a wild time as the character. It’s the same boots filled with The Wolverine, but we can live with it.
The $120 million budgeted threequel has topped the box office for its second weekend with $26.1 million. That’s a better hold than both predecessors, even if its domestic total thus far hasn’t even surpassed $100 million. We’d expect a $140 million domestic finish with a conventional rate of legs. Overseas, it has been a nicer touch, and with only a 44% dip, we can expect a comfortable worldwide gross surpassing $450 million, maybe $500 million. Thus far, the threequel has earned $317 million worldwide. Someone learned on the Sony side, unlike Warner Brothers, that lowering your budget for an upcoming sequel (that isn’t regarded as necessary) can still give you a remote sense of profitability, even with one of your predecessors accidentally overperforming several years prior.
The Wild Robot has reinvigorated its legs while on PVOD, earning $7.55 million domestically on its sixth weekend. It has passed $270 million worldwide, and maybe a $320 million worldwide total will put it in the old glory days of Dreamworks with Megamind and Over the Hedge‘s totals. Movies succeeding in theaters will carry the robustness over to PVOD and vice versa. We’ll see if the “in development” The Wild Robot 2 can produce a severe dent a la Puss in Boots: The Last Wish, Madagascar 2, or Kung Fu Panda 3. In any case, Shrek 5 will have audiences turning their heads back towards Dreamworks’ revolution.
Smile 2 won’t be touching its predecessor in terms of legs or gross revenue, but it’s already past $110 million globally in its third weekend, and a $140-150 million worldwide finish is a pat on the back for Paramount Pictures. Conclave is rolling past $15 million domestically, while Here earned a middling $5 million in its debut.
Terrifier 3 is nearing $60 million worldwide. It’s the biggest film in raw domestic earnings for any R-rated or NC-17 titles on the market. You can’t beat a great story when it shows the market thrives in this pop culture sensation for an unprecedented success story for a lower-level IP. Like the Scream series, Art The Clown can hold down the fort as a modern-day slasher.
A24’s We Live in Time will get past $20 million domestically later this week, and Beetlejuice Beetlejuice is inching for $300 million domestically. Joker: Folie a Deux has crashed and burned with $202 million, not even one-fifth of its predecessor’s whopping totals, and Deadpool & Wolverine is wrapping up in the shop with $1.337 billion, the seventh most significant superhero feature of all time.
Next weekend sees the release of Heretic, The Best Christmas Pageant Ever, Elevation, and Bird.
